In addition, they also found that CMPB90–1 could increase T cell activity by inhibiting the programmed death ligand-1 (PD-L1)/programmed death -1 (PD-1) axis between tumor associated macrophage and T cells. The gene discussed is CD274; the disease is neoplasm.